Elis Ikeda
About Elis Ikeda
Elis Ikeda is a Senior Clinical Data Manager at Bristol Myers Squibb with over 19 years of experience in clinical data management.
Company
Elis Ikeda is currently employed at Bristol Myers Squibb, a renowned global biopharmaceutical company. Bristol Myers Squibb is recognized for its significant contributions to the development of innovative medicines aimed at addressing serious health issues. Elis holds the position of Senior Clinical Data Manager at the company, where they have been working for over 19 years. The company is headquartered in New York but operates on a global scale, which includes its operations in Brazil, where Elis is based.
Title
Elis Ikeda serves as a Senior Clinical Data Manager. In this role, Elis is responsible for overseeing the management and analysis of clinical data, ensuring the accuracy and integrity of this data throughout the clinical trial processes. Such roles are crucial to the success of clinical research and trials, impacting the development and approval of new medications.
Education and Expertise
Elis Ikeda studied at USP - Universidade de São Paulo from 1992 to 1996, thereby completing a four-year degree. USP is one of the most prestigious universities in Brazil, known for its strong emphasis on research and quality education. Elis’s academic background in this institution has provided a solid foundation for a career in clinical data management.
Professional Background
Elis Ikeda began their career in clinical data management at Merck Sharp & Dohme, where they worked as a Data Coordinator from 2003 to 2004 for 10 months. Following this, Elis joined Bristol Myers Squibb and has since accumulated over 19 years of experience in clinical data management at this company. Elis’s extensive career reflects deep expertise and a substantial contribution to the field.
Location and Career Duration
Elis Ikeda has been based in São Paulo, Brazil, throughout their professional career. With an enduring presence in the clinical data management sector, Elis has spent a significant portion of their career, spanning over two decades, contributing to the development and management of clinical data at reputable biopharmaceutical companies.